Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
  Top » Catalog » Books » Biology » Proteins » Serpins and Protein Kinase Inhibitors: Novel Functions, Structural Features and Molecular Mechanisms Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Theory of Literature
Shopping Cart more
0 items
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Serpin-Related Diseases pp.1-36
Tell A Friend
Tell someone you know about this product.
Serpin-Related Diseases pp.1-36 $100.00
Authors:  (Aleksandra Topic—Institute of Medical Biochemistry, Faculty of Pharmacy, Belgrade, Serbia)
Serpins play a critical role in maintaining homeostasis. Approximately two-thirds of human serpins perform extracellular roles, and the rest are localized and function intracellular. There are inhibitory and non-inhibitory serpins. In maintaining homeostasis, serpins are involved in a number of fundamental biological processes such as extracellular matrix remodeling, pro-hormone conversion, intracellular proteolysis, blood pressure, tumor suppression, hormone transport, viral/parasite pathogenicity, modulation of inflammatory response, cell differentiation, cell migration, protein folding, fibrinolysis, complement cascade and blood coagulation.
Severe, human serpin-related diseases are emphysema, liver disease, massive thrombosis or bleeding, hereditary angioedema, dementia, angiopathy and tumor invasion. Inhibitory serpins are „suicide‟ or „single use‟ inhibitors that use a unique and extensive conformational change to inhibit proteinases. One hallmark of serpins is the reactive centre loop (RCL), a protein motif with a scissile bond, which is cleave by the target proteinase. The structure of the RCL is crucial for the ability of the protein to undergo a „stressed to relaxed‟ (S→R) conformational change. The active serpins are in metastable „stressed form‟, which is essential for their inhibition role. They can be present in various conformations: native inhibitory with an exposed RCL, latent with a partially inserted RCL or non-inhibitory due to complex formation, cleavage, oxidation of reactive centre residues or polymerization. Any mechanism which reduces the functional level of serpins such as oxidative inactivation, inactivation by non-target proteinases or genetic aberration (mutations), may lead to the pathological process. Serpins are especially vulnerable to mutations, which could alter their native conformations. Aberrations of conformation frequently occur and could lead to a range of diseases that are grouped together and named as the serpinopathies. Nowadays, well-established serpinopathies that reflect the functions and site of synthesis of the individual serpins are emphysema, cirrhosis, thrombosis and dementia. More than 200 different serpins mutations have been identified as the cause of various diseases. Mutations which cause inappropriate conformational change (or misfolding) results in two common outcomes. One is a promotion inappropriate transition to the monomeric latent state with reduction of active inhibitory serpin (antithrombin variants), and the other is serpin polymerization, when the RCL of one serpin molecule inserts into β-sheet A of another to form a dimer, which subsequently extends to form long chains of inactive polymers (alpha-1-antitrypsin variants). 

Available Options:
This Item Is Currently Unavailable.
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2020

Serpin-Related Diseases pp.1-36